Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Delight of Perusing: Book Proposals for Each Class - 2Most loved VR Game for Wellness: Which Keeps You Dynamic?
- 3Empathy and reasoning aren’t rivals – new research shows they work together to drive people to help more
- 4Posts falsely claim Netanyahu video fabricated to cover up his death
- 5Vote in favor of the Top Vegetable for Senior
- Instructions to Utilize Your Brain science Certification to Work on Corporate Culture
- Twins were the norm for our ancient primate ancestors − one baby at a time had evolutionary advantages
- Ukraine's naval drones are gunning for Russia's 'shadow fleet.' A security source says a tanker just suffered a critical hit.
- Extremely Rare Snub-Nosed Monkey Was Just Born for the First Time Outside of Asia
- Linda Hamilton, 69, says she doesn't want to 'chase longevity'
- Did Japan’s PM Actually Back the Memecoin Bearing Her Name?
- 6 Exercises to Anticipate in 2024
- RFK Jr.'s vaccine panel delays hepatitis B shot vote after chaotic meeting
- Arctic sea ice just dropped to an alarming new low
